Sapphiros, a US-based platform involved in building the next generation of consumer diagnostics, announced on Tuesday that it has named Jackson McAdam as its new chief financial officer.
In the new role, McAdam will be responsible for managing the company's global finance and information technology functions.
McAdam has served as the chief financial officer at Cytrellis Biosystems, CFO at AgaMatrix Diabetes and served in senior leadership positions at Kronos Incorporated. He has served for several years as a senior auditor at PricewaterhouseCoopers.
Mark Gladwell, Sapphiros CEO, said: "We are excited for Jackson to join our team. Our company's continued financial strength is essential for us to deliver on our vision, and Jackson brings a wealth of financial experience, a track record of achievement and insights into healthcare technology and healthcare systems, enabling us to accelerate our efforts in commercialising our product portfolio and ensuring strong fiscal growth."
Lifecare sensor achieves 9-week longevity in dog trial
RedHill Biopharma reports promising results for opaganib in obesity and diabetes studies
Sumitomo Pharma and Poxel report positive results from TWYMEEG study in Japan
Sapphiros names new chief financial officer
Amylyx receives EU Orphan Drug Designation for Wolfram syndrome treatment
KVK Tech registers Lomaira 8mg tablets in Mexico
GSK's Arexvy receives positive CHMP opinion for at-risk adults aged 50-59
M8 Pharmaceuticals signs exclusive licensing and distribution agreement with LG Chem
FDA feedback boosts Diamyd Medical's pathway to accelerated approval for Type 1 Diabetes Therapy